采用抗胸腺细胞球蛋白(atg)或抗淋巴细胞球蛋白(ALG)免疫疗法是不适宜于骨髓移植患儿的主要治疗方法。
Immunotherapy with either antithymocyte globulin (ATG) or antilymphocyte globulin (ALG) is the primary treatment for those children not candidates for bone marrow transplant.
目的分析异体造血干细胞移植前加用抗T淋巴细胞球蛋白（ATG）预防移植物抗宿主反应（GVHD）的疗效。
Objective To analyze effects of antithymocyte globulin(ATG) in preventing the occurrence of graft-versus-host disease(GVHD) in allogeneic stem cells transplantation.
对热原不合格的抗淋巴细胞免疫球蛋白（ALG）半制品再制条件进行了研究。
The reproductive conditions of anti-lymphocyte immunoglobulin(ALG) semi-finished product unqualified in pyrogen were studied.
对热原不合格的抗淋巴细胞免疫球蛋白（ALG）半制品再制条件进行了研究。
The reproductive conditions of anti-lymphocyte immunoglobulin(ALG) semi-finished product unqualified in pyrogen were studied.
应用推荐